Transition states of native and drug-resistant HIV-1 protease are the same
- 9 April 2012
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (17) , 6543-6548
Abstract
HIV-1 protease is an important target for the treatment of HIV/AIDS. However, drug resistance is a persistent problem and new inhibitors are needed. An approach toward understanding enzyme chemistry, the basis of drug resistance, and the design of powerful inhibitors is to establish the structure of enzymatic transition states. Enzymatic transition structures can be established by matching experimental kinetic isotope effects (KIEs) with theoretical predictions. However, the HIV-1 protease transition state has not been previously resolved using these methods. We have measured primary 14 C and 15 N KIEs and secondary 3 H and 18 O KIEs for native and multidrug-resistant HIV-1 protease (I84V). We observed 14 C KIEs ( 14 V / K ) of 1.029 ± 0.003 and 1.025 ± 0.005, 15 N KIEs ( 15 V / K ) of 0.987 ± 0.004 and 0.989 ± 0.003, 18 O KIEs ( 18 V / K ) of 0.999 ± 0.003 and 0.993 ± 0.003, and 3 H KIEs ( 3 V / K ) KIEs of 0.968 ± 0.001 and 0.976 ± 0.001 for the native and I84V enzyme, respectively. The chemical reaction involves nucleophilic water attack at the carbonyl carbon, proton transfer to the amide nitrogen leaving group, and C-N bond cleavage. A transition structure consistent with the KIE values involves proton transfer from the active site Asp-125 (1.32 Å) with partial hydrogen bond formation to the accepting nitrogen (1.20 Å) and partial bond loss from the carbonyl carbon to the amide leaving group (1.52 Å). The KIEs measured for the native and I84V enzyme indicate nearly identical transition states, implying that a true transition-state analogue should be effective against both enzymes.Keywords
This publication has 51 references indexed in Scilit:
- Mass-Dependent Bond Vibrational Dynamics Influence Catalysis by HIV-1 ProteaseJournal of the American Chemical Society, 2011
- Arsenate and Phosphate as Nucleophiles at the Transition States of Human Purine Nucleoside PhosphorylaseBiochemistry, 2011
- Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV‐1 protease: Relevance to drug resistanceProtein Science, 2010
- The Catalytic Mechanism of an Aspartic Proteinase Explored with Neutron and X-ray DiffractionJournal of the American Chemical Society, 2008
- Caught in the Act: The 1.5 Å Resolution Crystal Structures of the HIV-1 Protease and the I54V Mutant Reveal a Tetrahedral Reaction IntermediateBiochemistry, 2007
- Transition-State Structure of Human 5‘-Methylthioadenosine PhosphorylaseJournal of the American Chemical Society, 2006
- Kinetic, Stability, and Structural Changes in High-resolution Crystal Structures of HIV-1 Protease with Drug-resistant Mutations L24I, I50V, and G73SJournal of Molecular Biology, 2005
- Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by oxygen-18 isotope exchangeBiochemistry, 1991
- Peptide substrates and inhibitors of the HIV-1 proteaseBiochemical and Biophysical Research Communications, 1989
- Synthesis and back exchange of18O labeled amino acids for use as internal standards with mass spectrometryJournal of Mass Spectrometry, 1979